NCT07222475Recruiting
Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
This research aims to see if songwriting can help reduce anxiety in adolescents with Sickle Cell Disease. The purpose of the study is to discover if participants find songwriting and playing their songs to be practical and acceptable, and helpful for managing anxiety.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 27 Oct 2025
- Start date
- 5 Feb 2026
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Mayo Clinic
- Diseases
- Sickle cell disease
- NCT number
- NCT07222475
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 5 Feb 2026 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Visual, hearing, or cognitive impairment which may impede the ability to complete the songwriting intervention or data collection measures
Other
- Care transitioned to adult facility
Who the study is looking for
- Adolescents aged 11-18 years of age at the time of enrollment and able to provide assent
- Diagnosed with any type of sickle cell disease
- Currently receiving care at pediatric center
- Able to read and write in English
Age in the registry: 11 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Division of Nursing Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.